Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Guidant Clarifies J&J Merger Terms, Incentives For Execs, Antitrust Defense

This article was originally published in The Gray Sheet

  • News

Executive Summary

Antitrust regulators weighing the potential impact of a J&J/Guidant merger on the DES market are likely to be mollified by the number of firms with drug-eluting stents in development, Guidant CEO Ron Dollens says

You may also be interested in...



J&J Ups Negotiation Dance With Guidant To Get Reduced Price After Recalls

Johnson & Johnson will need to weigh the risks of trying to renegotiate its $24 bil. acquisition of Guidant with its interest in entering the rapidly-expanding ICD market

J&J Ups Negotiation Dance With Guidant To Get Reduced Price After Recalls

Johnson & Johnson will need to weigh the risks of trying to renegotiate its $24 bil. acquisition of Guidant with its interest in entering the rapidly-expanding ICD market

AngioDynamics Aims To Leverage Endovenous Laser Reimbursement

AngioDynamics is developing "more aggressive" marketing efforts for its VenaCure laser ablation system on the heels of favorable Medicare reimbursement codes and rates for 2005

Table

View full table

Tags:
Latest Headlines

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

See All
UsernamePublicRestriction

Register

MT021392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By